Vanta Bioscience Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹51.14
- Today's High:
- ₹53.79
- Open Price:
- ₹51.15
- 52W Low:
- ₹39.9
- 52W High:
- ₹99
- Prev. Close:
- ₹53.83
- Volume:
- 2250
Company Statistics
- Market Cap.:
- ₹852.12 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Vanta Bioscience Limited had its IPO on under the ticker symbol 540729.
The company operates in the Other sector and Other industry. Vanta Bioscience Limited has a staff strength of 0 employees.
Stock update
Shares of Vanta Bioscience Limited opened at ₹51.15 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹51.14 - ₹53.79, and closed at ₹51.14.
This is a -5% slip from the previous day's closing price.
A total volume of 2,250 shares were traded at the close of the day’s session.
In the last one week, shares of Vanta Bioscience Limited have slipped by -13.03%.
Vanta Bioscience Limited's Key Ratios
Vanta Bioscience Limited has a market cap of ₹852.12 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Vanta Bioscience Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Vanta Bioscience Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vanta Bioscience Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Vanta Bioscience Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Vanta Bioscience Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vanta Bioscience Limited’s profitability.
Vanta Bioscience Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Vanta Bioscience Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹847.09 million
- Total Liabilities
- ₹177.47 million
- Operating Cash Flow
- ₹-59087000.00
- Capital Expenditure
- ₹286.89 million
- Dividend Payout Ratio
- 0%
Vanta Bioscience Limited ended 2024 with ₹847.09 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹847.09 million while shareholder equity stood at ₹175.15 million.
Vanta Bioscience Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹177.47 million in other current liabilities, 63120000.00 in common stock, ₹112.03 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹966000.00 and cash and short-term investments were ₹966000.00. The company’s total short-term debt was ₹100,845,000 while long-term debt stood at ₹470.67 million.
Vanta Bioscience Limited’s total current assets stands at ₹152.43 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹19.59 million compared to accounts payable of ₹42.19 million and inventory worth ₹71.58 million.
In 2024, Vanta Bioscience Limited's operating cash flow was ₹-59087000.00 while its capital expenditure stood at ₹286.89 million.
Comparatively, Vanta Bioscience Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹51.14
- 52-Week High
- ₹99
- 52-Week Low
- ₹39.9
- Analyst Target Price
- ₹
Vanta Bioscience Limited stock is currently trading at ₹51.14 per share. It touched a 52-week high of ₹99 and a 52-week low of ₹99. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹52.03 and 200-day moving average was ₹80.56 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.